Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cequent Pharmaceuticals

2003 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
$46M LATEST DEAL AMOUNT
Description

Developer of RNAi based therapies. The company focuses on biopharmaceutical products based on RNA interference (RNAi) to prevent and treat a range of human diseases, such as inflammatory diseases and cancer.

Formerly Known As
Cequent
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Acquirer
Primary Office
  • One Kendall Square
  • Building 700, 1st Floor
  • Cambridge, MA 02139
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cequent Pharmaceuticals’s full profile, request a free trial.

Cequent Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Apr-2010 $46M 000.00 0000 Completed Product Development
2. Later Stage VC (Series A1) 30-Oct-2009 00.000 000.00 000.00 Completed Product Development
1. Early Stage VC (Series A) 15-Aug-2008 $14.8M $14.8M 000.00 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Cequent Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A1 0,000,000 00.000000 00 00 00 00 00.00 0.000
Series A 00,000,000 00.000000 00 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

Cequent Pharmaceuticals Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Ampersand Capital Partners Growth/Expansion Minority 000 0000 000000 0
NMT Capital PE/Buyout Minority 000 0000 000000 0
New England Partners PE/Buyout Minority 000 0000 000000 0
Novartis Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
Pappas Capital Venture Capital Minority 000 0000 000000 0